Centocor, Inc.
🏢 View company profile →150Patents
41Active
150Granted
46Portfolio score
Filing activity: May 7, 1982 → Oct 8, 2010 · 41 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5656272A | Methods of treating TNF-.alpha.-mediated Crohn's disease using chimeric anti-TNF antibodies | Chemistry; Metallurgy | 273 | Expired |
| US7250165B2 | Anti-TNF antibodies, compositions, methods and uses | Emerging Cross-Sectional Technologies | 187 | Expired |
| US7070775B2 | Recombinant A2-specific TNFα specific antibodies | Chemistry; Metallurgy | 174 | Expired |
| US5698195A | Methods of treating rheumatoid arthritis using chimeric anti-TNF antibodies | Chemistry; Metallurgy | 173 | Expired |
| US4591570A | Matrix of antibody-coated spots for determination of antigens | Emerging Cross-Sectional Technologies | 144 | Expired |
| US5919452A | Methods of treating TNF.alpha.-mediated disease using chimeric anti-TNF antibodies | Chemistry; Metallurgy | 141 | Expired |
| US5770198A | Platelet-specific chimeric 7E3 immunoglobulin | Chemistry; Metallurgy | 136 | Expired |
| US7276239B2 | Recombinant A2-specific TNFα-specific antibodies | Chemistry; Metallurgy | 131 | Expired |
| US6277969A | Anti-TNF antibodies and peptides of human tumor necrosis factor | Chemistry; Metallurgy | 117 | Expired |
| US7291721B2 | Anti-IL-6 antibodies, compositions, methods and uses | Chemistry; Metallurgy | 110 | Expired |
| US7163681B2 | Anti-integrin antibodies, compositions, methods and uses | Emerging Cross-Sectional Technologies | 101 | Expired |
| US7192584B2 | Methods of treating psoriasis with anti-TNF antibodies | Chemistry; Metallurgy | 101 | Expired |
| US6284471A | Anti-TNFa antibodies and assays employing anti-TNFa antibodies | Chemistry; Metallurgy | 99 | Expired |
| US4510119A | Diagnostic test bead transfer apparatus | Emerging Cross-Sectional Technologies | 98 | Expired |
| US6902734B2 | Anti-IL-12 antibodies and compositions thereof | Chemistry; Metallurgy | 83 | Expired |
| US7521206B2 | Anti-TNF antibodies, compositions, methods and uses | Emerging Cross-Sectional Technologies | 81 | Expired |
| US5118796A | Efficient large-scale purification of immunoglobulins and derivatives | Emerging Cross-Sectional Technologies | 78 | Expired |
| US7612182B2 | Anti-IL-6 antibodies, compositions, methods and uses | Chemistry; Metallurgy | 72 | Active |
| US7179893B2 | Recombinant anti-TNF-α antibodies | Chemistry; Metallurgy | 67 | Expired |
| US5223395A | Immunometric assays for tumor necrosis factor-alpha and methods for preventing the loss of biological activity of tumor necrosis factor-alpha in biological samples | Physics | 64 | Expired |
| US5618785A | Peptide inhibitors of selectin binding | Human Necessities | 64 | Expired |
| US5648471A | One vial method for labeling antibodies with Technetium-99m | Human Necessities | 63 | Expired |
| US7955597B2 | Anti-IL-6 antibodies, compositions, methods and uses | Chemistry; Metallurgy | 63 | Active |
| US5710123A | Peptide inhibitors of selectin binding | Human Necessities | 63 | Expired |
| US6835823B2 | Anti-TNF antibodies and peptides of human tumor necrosis factor | Chemistry; Metallurgy | 61 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.